---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-037635"
form_type: "8-K"
ticker: null
cik: "0001121702"
company_name: "YIELD10 BIOSCIENCE, INC."
filed_at: "2024-03-22T23:59:59+00:00"
generated_at: "2026-06-04T08:58:40.914586+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Yield10 Bioscience induces exercise of 3.19M warrants at $0.43/share, issues 6.38M new warrants

## Summary
- Existing institutional investors exercise 3,191,140 warrants for cash at reduced exercise price of $0.43 per share.
- Company issues new unregistered warrants to purchase up to 6,382,280 shares (200% of exercised shares) at $0.43/share.
- New warrants exercisable for five years from shareholder approval date, subject to 9.99% beneficial ownership limitation.
- Company to seek shareholder approval within 90 days for issuance of new warrants and underlying shares.
- Maxim Group LLC acting as warrant solicitation agent; receives 7.0% cash fee on total proceeds from exercised warrants.

## SEC filing metadata
- accession: 0001104659-24-037635
- form_type: 8-K
- cik: 0001121702
- company_name: YIELD10 BIOSCIENCE, INC.
- filed_at: 2024-03-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1121702/000110465924037635/0001104659-24-037635-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1121702/000110465924037635/tm249553d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-037635
- JSON: https://secwatch.observer/filing/0001104659-24-037635.json
- Plain text: https://secwatch.observer/filing/0001104659-24-037635.txt

## Key facts
- Material Agreements
  YIELD10 BIOSCIENCE, INC. entered into Agreements with certain existing institutional investors (effective 2024-03-22).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain existing institutional investors
  - Effective: 2024-03-22
  source text: On March 22, 2024, Yield10 Bioscience, Inc., a Delaware corporation (the “ Company ”), entered into warrant exercise agreements (the “ Agreements ”) with certain existing institutional investors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1121702/000110465924037635/0001104659-24-037635-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.